NDT Advance Access originally published online on September 23, 2006
Nephrology Dialysis Transplantation 2007 22(1):187-195; doi:10.1093/ndt/gfl502
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Confounding effect of comorbidity in survival studies in patients on renal replacement therapy
1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, 2ERA–EDTA Registry, Dept. of Medical Informatics, Academic Medical Center – University of Amsterdam, Amsterdam, The Netherlands, 3Catalan Renal Registry (RMRC), Catalan Transplant Organisation, Catalan Health Service, Autonomous Government of Catalonia, Barcelona, Spain, 4Registro Lombardo Dialisi e Trapianto, "Ospedale UBOLDO", Cernusco S/N, Milano, Italy, 5The UK Renal Registry, Southmead Hospital, Bristol, UK, 6Austrian Dialysis and Transplant Registry (OEDTR), General Hospital of Wels, Wels, Austria, 7Norwegian Renal Registry, Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway and 8Institut National de la Santé et de la Recherche Médicale, INSERM Unité 258, Villejuif, France
Correspondence and offprint requests to: Kitty J. Jager, ERA-EDTA Registry, Department of Medical Informatics, J1B-125, Academic Medical Center, PO Box 22700, 1100 DE Amsterdam, The Netherlands. Email: k.j.jager{at}amc.uva.nl
 |
Abstract |
|---|
Background. After taking other confounding factors into account, the impact of comorbidity on mortality was investigated when comparing mortality between five European countries, dialysis modalities and renal disease groups.
Methods. The study included 15 571 incident patients on renal replacement therapy (RRT) from five national or regional registries participating in the European Renal Association—European Dialysis and Transplant Association Registry that collect comorbidity data. The presence of diabetes mellitus, ischaemic heart disease, peripheral vascular disease, cerebrovascular disease and malignancy was recorded at the start of RRT.
Results. The comorbidities were each independently associated with mortality, with hazard ratios (HRs) ranging from 1.40 (95% CI: 1.30–1.51) for peripheral vascular disease to 1.65 (95% CI: 1.48–1.83) for diabetes. Age, gender, primary renal disease, modality and country together explained 14.4% of the variance in mortality; the comorbidities explained an additional 1.9%. In the comparison of renal vascular disease with glomerulonephritis, the crude HR of 2.40 (95% CI: 2.12–2.72) changed to 1.24 (95% CI: 1.09–1.41) after adjustment for age, gender, primary renal disease, treatment modality and country and to 1.06 (95% CI: 0.93–1.22) after further adjustment for the comorbidities. For the comparison between countries and other patient groups, the change in the survival estimate after adjustment for comorbidity was less.
Conclusion. Comorbidity is an important predictor for mortality. However, after adjustment for age, gender, primary renal disease, treatment modality and country, when comparing outcomes between patient groups the influence of comorbidity may be less important than expected.
Keywords: comorbidity; confounding; renal replacement therapy; survival
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Sawhney, O. Djurdjev, K. Simpson, A. Macleod, and A. Levin Reply Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3896 - 3896. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Miskulin, J. Bragg-Gresham, B. W. Gillespie, F. Tentori, R. L. Pisoni, H. Tighiouart, A. S. Levey, and F. K. Port Key Comorbid Conditions that Are Predictive of Survival among Hemodialysis Patients Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1818 - 1826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sawhney, O. Djurdjev, K. Simpson, A. Macleod, and A. Levin Survival and dialysis initiation: comparing British Columbia and Scotland registries Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3186 - 3192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Karamadoukis, D. Ansell, R. N. Foley, S. P. McDonald, C. R. V. Tomson, L. Trpeski, and F. J. Caskey Towards case-mix-adjusted international renal registry comparisons: how can we improve data collection practice? Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2306 - 2311. [Full Text] [PDF]
|
|
|
|
|
|
K. J. Jager and C. Zoccali Comorbidity data collection by renal registries--a remaining challenge Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2311 - 2313. [Full Text] [PDF]
|
|
|
|
|
|
P. Saudan, M. Kossovsky, G. Halabi, P. Y. Martin, T. V. Perneger, and for the Western Switzerland Dialysis Study Group Quality of care and survival of haemodialysed patients in western Switzerland Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1975 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Couchoud, O. Moranne, L. Frimat, M. Labeeuw, V. Allot, and B. Stengel Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3246 - 3254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Tentori, W. C. Hunt, M. Rohrscheib, M. Zhu, C. A. Stidley, K. Servilla, D. Miskulin, K. B. Meyer, E. J. Bedrick, H. K. Johnson, et al. Which Targets in Clinical Practice Guidelines Are Associated with Improved Survival in a Large Dialysis Organization? J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2377 - 2384. [Abstract] [Full Text] [PDF]
|
|